Oncology, Haematology
Recognising immune-related adverse reactions to immune checkpoint inhibitors – A guide for Emergency Medicine doctors
Over the last decade, immune checkpoint inhibitors (ICIs) have changed the landscape of cancer treatment, but are associated with immune related adverse reactions (irARs) which can impact a wide variety of body organs or systems. These may manifest at any time during ICI therapy and even long after therapy cessation. As ICI use is becoming […]
DURATION
1 hr
PROFESSION
Specialist
# OF CREDITS
1
ACCREDITATION
RACP
EXPIRY DATE
2023-07-22
Over the last decade, immune checkpoint inhibitors (ICIs) have changed the landscape of cancer treatment, but are associated with immune related adverse reactions (irARs) which can impact a wide variety of body organs or systems. These may manifest at any time during ICI therapy and even long after therapy cessation.
As ICI use is becoming more widespread, emergency medicine doctors are often the first to recognise and diagnose irARs, and need to have a low threshold of suspicion. Early consultation with oncology colleagues, will help avoid the pitfalls of missed irAR diagnosis and suboptimal management.
This program is supported by an independent educational grant provided from Bristol-Myers Squibb (Australia) Limited. The content contained in this program, including views and opinions expressed by faculty do not represent those of MDBriefCase or the sponsor.
Faculty
Dr. Megan Lyle
Medical Oncologist
Queensland, Australia
Dr. George Plunkett
Emergency Physician
Victoria, Australia
Learning objectives
Upon completion of this continuing education program participants will be better able to:
- Describe immune checkpoint inhibitors’ mechanisms of action and recognise the broad spectrum and potential severity of immune related adverse reactions (irARs)
- Identify and manage irARs in hospital emergency departments (EDs)
- Appreciate the benefits of multidisciplinary management, including early oncology consultation
- Recognise the pitfalls of missed irAR diagnosis and suboptimal management
Accreditation
This interactive online learning activity is valued at 1 Hour of continuing education with RACP.
Fellows of The Royal Australasian College of Physicians (RACP) can claim CPD credits in MyCPD for participation in this course. www.racp.edu.au/mycpd (log in to MyCPD)
This program has been endorsed by the Clinical Oncology Society of Australia (COSA).
This course is approved for 1 ACEM CPD hour with The Australasian College for Emergency Medicine.
If you are completing this course for ACEM points and hold an ACEM ID, please provide this to us when you complete the course, in the 'Course Evaluation'.